For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

RSV causes respiratory symptoms ranging from mild, cold-like discomfort to illnesses like bronchiolitis or pneumonia ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.

Texas Department of State Health Services data showed less than 50 HMPV-positive cases each week in December across the state ...

The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.